Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2012; 2(6):589-596. doi:10.7150/thno.4295 This issue Cite

Research Paper

The Efficient Synthesis and Biological Evaluation of Novel Bi-Functionalized Sarcophagine for 64Cu Radiopharmaceuticals

Shuanglong Liu1, Dan Li1,2, Chiun-Wei Huang1, Li-Peng Yap1, Ryan Park1, Hong Shan2, Zibo Li1✉, Peter S. Conti1✉

1. Department of Radiology, Keck School of Medicine, Molecular Imaging Center, University of Southern California, Los Angeles, CA 90033, USA
2. Department of Radiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China

✉ Corresponding author: Tel.: +1 323 442 3858; fax: +1 323 442 3253. Email: pcontiedu (P.S. Conti). Tel.: +1 323 442 3252; fax: +1 323 442 3253. Email: ziboliedu (Z. Li)

Citation:
Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti PS. The Efficient Synthesis and Biological Evaluation of Novel Bi-Functionalized Sarcophagine for 64Cu Radiopharmaceuticals. Theranostics 2012; 2(6):589-596. doi:10.7150/thno.4295. https://www.thno.org/v02p0589.htm
Other styles

File import instruction

Abstract

Purpose We and others have reported that Sarcophagine-based bifunctional chelators could be effectively used in the syntheses of 64Cu radiopharmaceuticals. The resulted 64Cu-Sarcophagine complexes demonstrated great in vivo stability. The goal of this study was to further derivatize Sarcophagine cage with amino and maleimide functional groups for conjugation with bioligands.

Methods Starting from DiAmSar, three novel chelators (AnAnSar, BaMalSar, and Mal2Sar) with two functional groups have been synthesized. Among those, BaMalSar and Mal2Sar have been conjugated with cyclic peptide c(RGDyC) (denoted as RGD) and the resulted conjugates, BaMalSar-RGD and Mal2Sar-RGD2 have been labeled with 64Cu. The tumor targeting efficacy of 64Cu-labeled RGD peptides were evaluated in a subcutaneous U87MG glioblastoma xenograft model.

Results The conjugates, BaMalSar-RGD and Mal2Sar-RGD2 could be labeled with 64CuCl2 in 10 min with high purity (>98%) and high radiochemical yield (>90%). Both 64Cu-BaMalSar-RGD and 64Cu-Mal2Sar-RGD2 exhibited high tumor uptake and tumor-to-normal tissue ratios.

Conclusion Three novel chelators with two functional groups have been developed based on Sarcophagine cage. The platform developed in this study could have broad applications in the design and synthesis of 64Cu-radiopharmaceuticals.

Keywords: Sarcophagine, 64Cu, microPET, RGD, Integrin αvβ3

Citation styles

APA
Liu, S., Li, D., Huang, C.W., Yap, L.P., Park, R., Shan, H., Li, Z., Conti, P.S. (2012). The Efficient Synthesis and Biological Evaluation of Novel Bi-Functionalized Sarcophagine for 64Cu Radiopharmaceuticals. Theranostics, 2(6), 589-596. https://doi.org/10.7150/thno.4295.

ACS
Liu, S.; Li, D.; Huang, C.W.; Yap, L.P.; Park, R.; Shan, H.; Li, Z.; Conti, P.S. The Efficient Synthesis and Biological Evaluation of Novel Bi-Functionalized Sarcophagine for 64Cu Radiopharmaceuticals. Theranostics 2012, 2 (6), 589-596. DOI: 10.7150/thno.4295.

NLM
Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti PS. The Efficient Synthesis and Biological Evaluation of Novel Bi-Functionalized Sarcophagine for 64Cu Radiopharmaceuticals. Theranostics 2012; 2(6):589-596. doi:10.7150/thno.4295. https://www.thno.org/v02p0589.htm

CSE
Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti PS. 2012. The Efficient Synthesis and Biological Evaluation of Novel Bi-Functionalized Sarcophagine for 64Cu Radiopharmaceuticals. Theranostics. 2(6):589-596.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use